Cancer research goes platinum

April 4, 1997

Chemists at Edinburgh University have launched a Pounds 145,000 project to develop more effective platinum-based anti-cancer drugs. Two versions of these drugs are used on testicular cancer and ovarian carcinoma. The work at Edinburgh could help in the design of new platinum compounds which are active against a wider range of cancers and have less toxic side-effects. It is funded by the Biotechnology and Biological Sciences Research Council (*see research papers).

You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments